First-in-Patient Study of OTL78 for Intraoperative Fluorescence Imaging of PSMA-Positive Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial
Lancet Oncol 2023 Apr 13;[EPub Ahead of Print], JA Stibbe, HA de Barros, DGJ Linders, SS Bhairosingh, EM Bekers, PJ van Leeuwen, PS Low, SA Kularatne, AL Vahrmeijer, J Burggraaf, HG van der PoelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.